Immunosuppressive Therapy and Risk of COVID-19 Infection in Patients With Inflammatory Bowel Diseases. Burke KE, Kochar B, Allegretti JR, Winter RW, et al. Inflamm Bowel Dis 2021;27:155-161.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Burke KE, Kochar B, Allegretti JR, Winter RW, et al. Immunosuppressive Therapy and Risk of COVID-19 Infection in Patients With Inflammatory Bowel Diseases. Inflamm Bowel Dis 2021;27:155-161.
PMID: 33089863